EFFECTS OF THE NEW ORAL ANGIOTENSIN CONVERTING ENZYME-INHIBITOR MK-421 IN HUMAN HYPERTENSION

被引：19
|
作者：
GAVRAS, H
BIOLLAZ, J
WAEBER, B
BRUNNER, HR
GAVRAS, I
DAVIES, RO
机构：
[1] BOSTON CITY HOSP, THORNDIKE MEM LAB, BOSTON, MA 02118 USA
[2] CHU LAUSANNE, LAUSANNE, SWITZERLAND
[3] MERCK SHARP & DOHME, West Point, PA 19486 USA
来源：
CLINICAL AND EXPERIMENTAL HYPERTENSION | 1982年 / 4卷 / 1-2期
关键词：
D O I：
10.3109/10641968209061593
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：303 / 314
页数：12
相关论文
共 50 条
  • [21] ENALAPRIL(MK-421), AN ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITOR - EFFECTS ON SYMPATHETIC NERVOUS-SYSTEM (SNS) FUNCTION DURING TREATMENT OF HYPERTENSION
    BERNSTEIN, KN
    MOSLEY, C
    OCONNOR, DT
    CERVENKA, J
    CLINICAL RESEARCH, 1983, 31 (02): : A246 - A246
  • [22] EFFECT OF THE CONVERTING ENZYME-INHIBITOR (CEI) MK-421 ON ISCHEMIC ACUTE-RENAL-FAILURE (ARF) IN THE RAT
    KOELZ, AM
    BRUNNER, FP
    WUNDERLICH, P
    THIEL, GT
    KIDNEY INTERNATIONAL, 1983, 23 (06) : 902 - 902
  • [23] ACUTE AND LONG-TERM RESPONSE TO MK-421, A LONG-ACTING ORAL CONVERTING ENZYME-INHIBITOR, IN HEART-FAILURE
    LEVINE, TB
    OLIVARI, MT
    COHN, JN
    CIRCULATION, 1982, 66 (04) : 209 - 209
  • [24] ANTIHYPERTENSIVE EFFICACY OF MK-421 (AN ANGIOTENSIN CONVERTING ENZYME-INHIBITOR, CEI) AND HYDROCHLOROTHIAZIDE (HTZ) IN CONSCIOUS DAHL SENSITIVE (S) AND RESISTIVE (R) RATS
    SHARMA, JN
    FERNANDEZ, PG
    KIM, BK
    TRIGGLE, CR
    CLINICAL RESEARCH, 1983, 31 (02): : A335 - A335
  • [25] PREVENTION OF DIURETIC-INDUCED SECONDARY HYPER-ALDOSTERONISM AND HYPOKALEMIA BY A NEW NON-SULFHYDRYL ANGIOTENSIN CONVERTING ENZYME-INHIBITOR (ACEI), MK-421
    GRIFFING, GT
    AURECCHIA, SA
    SINDLER, BH
    WILSON, T
    MELBY, JC
    CLINICAL RESEARCH, 1982, 30 (02): : A552 - A552
  • [26] EFFECTS OF AN ANGIOTENSIN CONVERTING ENZYME-INHIBITOR ON PSYCHOSOCIAL HYPERTENSION IN MICE
    HENRY, JP
    VANDER, AJ
    STEPHENS, PM
    CLINICAL SCIENCE, 1979, 57 : S153 - S155
  • [27] EFFICACY OF AN ORAL ANGIOTENSIN CONVERTING ENZYME-INHIBITOR (CAPTOPRIL) IN SEVERE HYPERTENSION
    ZWEIFLER, AJ
    JULIUS, S
    NICHOLLS, MG
    CLINICAL RESEARCH, 1979, 27 (02): : A320 - A320
  • [28] EFFECTS OF ENALAPRIL, A NEW CONVERTING ENZYME-INHIBITOR, IN HYPERTENSION
    FERGUSON, RK
    VLASSES, PH
    SWANSON, BN
    MOJAVERIAN, P
    HICHENS, M
    IRVIN, JD
    HUBER, PB
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 32 (01) : 48 - 53
  • [29] CORRELATION BETWEEN ANGIOTENSIN CONVERTING ENZYME-INHIBITION AND THE ACUTE HYPOTENSIVE RESPONSE TO MK-421 IN ESSENTIAL-HYPERTENSION
    JACKSON, B
    MCGRATH, BP
    JOHNSTON, CI
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1982, : 99 - 104
  • [30] ORAL CONVERTING ENZYME-INHIBITOR IN MALIGNANT HYPERTENSION
    GRISWOLD, W
    MCNEAL, R
    OCONNOR, D
    REZNIK, V
    MENDOZA, S
    ARCHIVES OF DISEASE IN CHILDHOOD, 1982, 57 (03) : 235 - 237
12345